Placebo of ZIMINO (glucose 5%), ZIMINO 2,5 mg/ml, solution à diluer pour perfusion
APHP200072
Phase 3 small_molecule active
Quick answer
Placebo of ZIMINO (glucose 5%), ZIMINO 2,5 mg/ml, solution à diluer pour perfusion for Patients referred for an isolated or a combined surgical correction of functional moderate to severe tricuspid regurgitation is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pari Pharma GmbH
- Indication
- Patients referred for an isolated or a combined surgical correction of functional moderate to severe tricuspid regurgitation
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active